Soterix Medical developed HD-tES as the first transcranial system capable of targeting the brain with weak electrical stimulation. HD-tES broke conventional thinking that only high-power magnetic or implanted electrodes could achieve focality. Soterix Medical has continued to innovate HD-tES by introducing Neurotargeting software for individualized programing, the first neuronavigation system for tES, and research-grade integration with EEG.
A programmable multi-channel stimulator is only effective when combined with tools to optimize neuromodulation. All HD systems are compatible with Soterix Medical Neurotargeting software that allows you to develop customized interventions. From 5 to 82 independently controlled stimulation channels, Soterix Medical provides scalable solutions that meet your need and provide expansive flexibility.
Exclusively from Soterix Medical
From the trusted leader in non-invasive neuromodulation, Soterix Medical HD-tES has been validated in rigorous clinical trials. When stimulation tolerability and reproducibility cannot be compromised researcher and clinicians choose Soterix Medical stimulation systems. All products come with expert Soterix Medical technical Soterix Medical support, documentation, and training.